Rapid attainment of target trough concentrations of tacrolimus for early improvement of clinical symptoms in patients with ulcerative colitis.
Yuto YamadaYuta OhnoTakashi NiwaHiroko Kato-HayashiHideki HayashiTakashi IbukaHiroshi ArakiTadashi SugiyamaMasahito ShimizuAkio SuzukiPublished in: Journal of clinical pharmacy and therapeutics (2019)
Our findings suggest that rapid attainment of the target trough concentration of tacrolimus improves clinical symptoms in patients with ulcerative colitis.